Tilray Brands Inc. (TLRY)
NASDAQ: TLRY
· Real-Time Price · USD
1.18
-0.07 (-5.60%)
At close: Aug 14, 2025, 3:59 PM
1.23
4.24%
Pre-market: Aug 15, 2025, 04:40 AM EDT
-5.60% (1D)
| Bid | 1.22 |
| Market Cap | 1.3B |
| Revenue (ttm) | 821.31M |
| Net Income (ttm) | -2.18B |
| EPS (ttm) | -2.46 |
| PE Ratio (ttm) | -0.48 |
| Forward PE | -4.59 |
| Analyst | Hold |
| Ask | 1.23 |
| Volume | 151,849,717 |
| Avg. Volume (20D) | 44,282,691 |
| Open | 1.15 |
| Previous Close | 1.25 |
| Day's Range | 1.13 - 1.37 |
| 52-Week Range | 0.35 - 1.98 |
| Beta | 1.95 |
About TLRY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLRY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TLRY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Tilray Brands Inc. is scheduled to release its earnings on
Oct 9, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+31.51%
Tilray Brands shares are trading higher on Wednesd...
Unlock content with
Pro Subscription
4 days ago
+41.82%
Shares of cannabis-related stocks are trading higher following a report suggesting President Trump is considering rescheduling marijuana as a Schedule III drug that would reclassify it as a less dangerous and ease restrictions.
4 days ago · proactiveinvestors.com
Cannabis stocks surge as Trump consider reclassifying the drugCannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a ...
